These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17034763)

  • 1. Transcriptional targeting of small interfering RNAs into cancer cells.
    Huynh T; Wälchli S; Sioud M
    Biochem Biophys Res Commun; 2006 Dec; 350(4):854-9. PubMed ID: 17034763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNAi expression vectors in mammalian cells.
    Miyagishi M; Taira K
    Methods Mol Biol; 2004; 252():483-91. PubMed ID: 15017073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expressing functional siRNAs in mammalian cells using convergent transcription.
    Tran N; Cairns MJ; Dawes IW; Arndt GM
    BMC Biotechnol; 2003 Nov; 3():21. PubMed ID: 14604435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term RNA interference from optimized siRNA expression constructs in adult mice.
    Wooddell CI; Van Hout CV; Reppen T; Lewis DL; Herweijer H
    Biochem Biophys Res Commun; 2005 Aug; 334(1):117-27. PubMed ID: 15993838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene silencing in androgen-responsive prostate cancer cells from the tissue-specific prostate-specific antigen promoter.
    Song J; Pang S; Lu Y; Yokoyama KK; Zheng JY; Chiu R
    Cancer Res; 2004 Nov; 64(21):7661-3. PubMed ID: 15520164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
    Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
    J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.
    Miyagishi M; Sumimoto H; Miyoshi H; Kawakami Y; Taira K
    J Gene Med; 2004 Jul; 6(7):715-23. PubMed ID: 15241778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.
    Griesenbach U; Kitson C; Escudero Garcia S; Farley R; Singh C; Somerton L; Painter H; Smith RL; Gill DR; Hyde SC; Chow YH; Hu J; Gray M; Edbrooke M; Ogilvie V; MacGregor G; Scheule RK; Cheng SH; Caplen NJ; Alton EW
    Respir Res; 2006 Feb; 7(1):26. PubMed ID: 16480492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fundamental study of small interfering RNAs for ganglioside GD3 synthase gene as a therapeutic target of lung cancers.
    Ko K; Furukawa K; Takahashi T; Urano T; Sanai Y; Nagino M; Nimura Y; Furukawa K
    Oncogene; 2006 Nov; 25(52):6924-35. PubMed ID: 16862187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and transfection of PCR products expressing siRNAs or shRNAs in mammalian cells.
    Castanotto D; Rossi JJ
    Methods Mol Biol; 2004; 252():509-14. PubMed ID: 15017076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy.
    Kim DH; Behlke MA; Rose SD; Chang MS; Choi S; Rossi JJ
    Nat Biotechnol; 2005 Feb; 23(2):222-6. PubMed ID: 15619617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonviral vector-mediated RNA interference: its gene silencing characteristics and important factors to achieve RNAi-based gene therapy.
    Takahashi Y; Nishikawa M; Takakura Y
    Adv Drug Deliv Rev; 2009 Jul; 61(9):760-6. PubMed ID: 19386274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preparation of small interfering RNA expression cassette based on PCR technique].
    Guo QY; Ma WL; Zhang B; Wu QH; Yan L; Zheng WL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Apr; 26(4):483-5, 489. PubMed ID: 16624759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of human UDP-glucose dehydrogenase expression using siRNA expression vector in breast cancer cells.
    Huh JW; Choi MM; Yang SJ; Yoon SY; Choi SY; Cho SW
    Biotechnol Lett; 2005 Aug; 27(16):1229-32. PubMed ID: 16158268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
    Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
    Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the adenosine 3',5'-cyclic monophosphate (cAMP) in enhancing the efficacy of siRNA-mediated gene silencing in neuroblastoma cells.
    Hanson AJ; Nahreini P; Andreatta C; Yan XD; Prasad KN
    Oncogene; 2005 Jun; 24(25):4149-54. PubMed ID: 15806165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression profiling reveals off-target gene regulation by RNAi.
    Jackson AL; Bartz SR; Schelter J; Kobayashi SV; Burchard J; Mao M; Li B; Cavet G; Linsley PS
    Nat Biotechnol; 2003 Jun; 21(6):635-7. PubMed ID: 12754523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of herpes simplex virus type 1-based amplicon vector for delivery of small interfering RNA.
    Sabbioni S; Callegari E; Manservigi M; Argnani R; Corallini A; Negrini M; Manservigi R
    Gene Ther; 2007 Mar; 14(5):459-64. PubMed ID: 17051250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase-3 gene silencing for inhibiting apoptosis in insulinoma cells and human islets.
    Cheng G; Zhu L; Mahato RI
    Mol Pharm; 2008; 5(6):1093-102. PubMed ID: 18828606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of MAT1 gene silencing mediated by siRNA in pancreatic cancer].
    Liu JP; Yuan SZ; Zhang SN
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(38):2719-23. PubMed ID: 18167254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.